All News

David Karp Tweet
DrDavidKarp
Congratulations @KenSaag the 85th President of @ACRheum Under your guidance we will flourish as a team that “is there for our members so they can be there for their patients”. #ACR21 #RheumatologyIsAmazing
Richard Conway Tweet
RichardPAConway
Long-term low dose glucocorticoid use associated ⬆️cardiovascular risk. Clear effect in Medicare population (older), not evident in Optum (younger). Dose dependent. Abstr#1915 #ACR21 @RheumNow https://t.co/oFet3Hhsfo
Dr. John Cush Tweet
RheumNow
Claims data looked at 21,114 #RA & #SLE pts - 4.3% had CV Death. The risk of CVD was worse w/ HCQ nonadherence (HR 1.08; 0.91-1.31) and better w/ HCQ adherence (HR 0.51;0.42-.66) HCQ nonadherence shows higher CV mortality #ACR21 Abst# 1909 https://t.co/di1mBliMN6
swethaann23 Tweet
swethaann23
Retrospective cohort study FORWARD databank : ⭐️ 🔼opioid use was associated with higher HAQ-DI and BASDAI scores among patients with PsA or AS Annualized avg opioid use and costs 🔼with 🔼HAQ-DI and BASDAI scores for patients in both cohorts Abst#1117 #ACRBest @RheumNow https://t.co/KB9QUITbAe
Meral K. El Ramahi, MD Tweet
MeralElRamahiMD
SpA & Pregnancy Outcomes? ➡️SpA pts txed w/ bDMARDs at conception are not at higher risk for adverse pregnancy outcomes compared to those w/o bDMARD ➡️Stopping bDMARDs after conception assoc w/ ↑ dz activity during pregnancy + after birth & ↑flares Abst#1730 #ACR21 @RheumNow https://t.co/Y4c7vI0cgS
Akhil Sood MD Tweet
AkhilSoodMD
Press Conference Arthritic Disease Abs 1451 Ologhobo & colleagues examined impact of virtual exercise program in individuals w/ MSK conditions Members reported decrease in - Pain - Pain interference - Fatigue - Stiffness #ACR21 @RheumNow https://t.co/T5qdlLEYZ0
Meral K. El Ramahi, MD Tweet
MeralElRamahiMD
*️⃣Abst#1800 observed that a changing pattern of purine, lipid, & amino acid metabolites occurred during transition from PsO to PsA. *️⃣Compared to pts w/ Pso that didn't progress to PsA, those that progressed had elevated levels of guanine! Potential biomarkers? #ACR21 @RheumNow https://t.co/iQh1ZapDMB
Janet Pope Tweet
Janetbirdope
Dementia is ⬆️in #RheumatoidArthritis says Elena Myasoedva but #RA has more DM &CV disease which ⬆️dementia. Need to separate vascular dementia from Alzheimer’s. When I trained we thought less dementia in RA -likely not true. More work is coming. 9T213 aging hub #ACR21 @RheumNow
Meral K. El Ramahi, MD Tweet
MeralElRamahiMD
Post-Hoc of the ASCORE trial showed the following b/l characteristics were most likely associated with remission (per DAS28, SDAI, CDAI) in mod-severe RA patients treated w/ SQ Abatacept: ⭐️Seropositivity ⭐️no prior bMDARD use ⭐️low HAQ-DI ⭐️low BMI Abst#1228 #ACR21 @Rheumnow https://t.co/NvJoSWScZs
swethaann23 Tweet
swethaann23
⭐️Immune phenotyping of 45 patients with Pso and 41 PsA pts showed a number of cell subsets significantly different in Pso vs PsA ⭐️Future possibility of using a combination of selected immune cell subsets as a method for detecting PsA in Pso pts Abst#1774 #ACR21 @Rheumnow https://t.co/ER1MPOvMa6
Meral K. El Ramahi, MD Tweet
MeralElRamahiMD
Abst#1774 identified a blood-based immune profile with a machine-learning approach that discriminates PsA from Pso. ➡️↑ proportions of differentiated CD4+CD196+CD183–CD194+ and CD4+CD196–CD183–CD194+ T-cells in PsA #ACR21 @RheumNow https://t.co/64uhJCd2qo
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×